The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III

Despite enormous advances in thoracic surgery and oncology, two critical issues concern patients undergoing curative-intent surgery for lung, gastric and esophageal cancer: first, a majority (\~60%) of patients experience minor and major adverse events occurring during and in the days following surgery; second, patients worry about the significant risk of cancer recurrence and mortality months to years after surgery. These issues, combined with side effects of chemotherapy and radiation, have detrimental effects on health-related quality of life (HRQoL). On a deeper level, there is the problem

Trial Details

NCT ID
NCT04871412
Phase
PHASE3
Sponsor
Ottawa Hospital Research Institute
Status
RECRUITING
Cancer Type
Lung Cancer
Interventions
  • Vitamin D3 Drops
  • Coriolus Versicolor
  • Trident SAP 66:33 Lemon
  • Probiotic Pro12
  • Provitalix Pure Whey Protein
  • Theracurmin 2X
Locations (sample)
  • Ottawa, Ontario, Canada|45.41117,-75.69812
  • Toronto, Ontario, Canada|43.70643,-79.39864

Key Eligibility Criteria

  • Adults eligible for complete resection of lung, gastric or esophageal cancer

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lung Cancer Trials on Trialify →